PREDICTORS OF LOSS OF CLINICAL REMISSION WITH ETANERCEPT 50 MG, 25 MG OR PLACEBO COMBINED WITH METHOTREXATE IN MODERATE RHEUMATOID ARTHRITIS PATIENTS: RESULTS OF THE PRESERVE TRIAL

Category Primary study
JournalANNALS OF THE RHEUMATIC DISEASES
Year 2013
This article has no abstract
Epistemonikos ID: 4647f6c0107a9fccdf9dfaa2b6c846cbead570ba
First added on: Mar 23, 2022